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BACKGROUND:  In low-income countries there is a great 
need for economical methods for testing the susceptibil-
ity of Mycobacterium tuberculosis to antibiotics. 
OBJECTIVE: To evaluate the thin-layer agar (TLA) for 
rapid detection of resistance to rifampicin (RMP), ofl  ox-
acin (OFX) and kanamycin (KM) in M. tuberculosis 
clinical isolates and to determine the sensitivity, specifi  -
city and time to positivity compared to the gold stand-
ard method.
METHODS: One hundred and forty-seven clinical iso-
lates of M. tuberculosis were studied. For the TLA 
method, a quadrant Petri plate containing 7H11 agar 
with RMP, OFX and KM was used. Results were com-
pared to the Bactec MGIT960 for RMP and the propor-
tion method for OFX and KM. 
RESULTS: The sensitivity and specifi  city for RMP and 
OFX were 100% and for KM they were 100% and 
98.7%, respectively. The use of a TLA quadrant plate 
enables the rapid detection of resistance to the three 
anti-tuberculosis drugs RMP, OFX and KM in a median 
of 10 days.
CONCLUSION: TLA was an accurate method for the 
detection of resistance in the three drugs studied. This 
faster method is simple to perform, providing an alter-
native method when more sophisticated techniques are 
not available in low-resource settings.
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THE EMERGENCE of multidrug-resistant tubercu-
losis (MDR-TB, defi  ned as resistance to both isoni-
azid [INH] and rifampicin [RMP]) and, more recently, 
extensively drug-resistant tuberculosis (XDR-TB, de-
fi  ned as MDR-TB with additional resistance to any 
fl  uoroquinolone [FQ] and to at least one of three in-
jectable second-line anti-tuberculosis drugs used in 
treatment: capreomycin [CPM], kanamycin [KM] or 
amikacin [AMK]), together with TB and human im-
munodefi  ciency virus (HIV) co-infection, have stressed 
the need for improved technologies for rapid detec-
tion of drug resistance in TB.1 Culture and drug sus-
ceptibility testing (DST) of Mycobacterium tubercu-
losis take several weeks due to the slow growth of the 
bacteria. Early detection of drug resistance could op-
timise treatment, improve the outcome for patients 
with drug-resistant TB and prevent the transmission 
of MDR-TB. 
Treatment of MDR-TB is complicated, as it requires 
the use of second-line drugs that are less effective 
and more toxic, demanding longer treatment periods. 
This situation poses a serious problem for low-income 
countries, especially in regions with a high prevalence 
of HIV infection. To achieve the ambitious new goals 
to treat MDR-TB recommended by the World Health 
Organization (WHO), laboratories must develop the 
capacity to perform DST of fi  rst- and second-line 
drugs to detect MDR- and XDR-TB using rapid meth-
ods.2 Fully automated commercial systems such as 
the Bactec Mycobacteria Growth Indicator Tube  960 
(MGIT960) have proved their reliability in the rapid 
detection of resistance to fi  rst- and second-line drugs, 
with results available within on average 10 days; how-
ever, they require heavy and costly equipment that is 
either not universally available or is not suit  able for 
poor countries. Several new methods have been devel-
oped to reduce the diagnostic time, such as the micro-
scopic observation drug susceptibility assay (MODS), 
the nitrate reductase assay (NRA) or the colorimetric 
redox-indicator assay.3–6 One of the new low-cost 
meth  ods for the diagnosis of TB is thin-layer agar 
(TLA), which is able to detect growth within 10 days 
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while also allowing the initial identifi  cation of M. tu-
berculosis based on its characteristic cording mor-
phology when observed microscopically.7,8 TLA is 
performed on solid media, and it does not require so-
phisticated equipment. 
Resistance to RMP can be considered a surrogate 
marker for MDR-TB, while KM and ofl  oxacin (OFX) 
are key second-line drugs for the treatment of TB in 
MDR-TB cases.1 The aim of the present study was to 
evaluate TLA for rapid detection of resistance to RMP, 
OFX and KM in M. tuberculosis and to determine 
the sensitivity, specifi  city and the time to detection of 
TLA compared to the gold standard method. 
MATERIALS AND METHODS
Strains
One hundred and forty-seven clinical isolates of M. tu-
berculosis, obtained from the collection at the Insti-
tute of Tropical Medicine in Antwerp, Belgium, were 
studied: 122 were MDR and 25 were drug-s usceptible. 
The reference strain M. tuberculosis H37Rv (Ameri-
can Type Culture Collection number 27294), was used 
as the reference susceptible control. All isolates were 
freshly subcultured on Löwenstein-Jensen (LJ) me-
dium before being tested by the different methods.
Antimicrobial agents
All drugs were in chemically pure powder. RMP 
(Sigma-Aldrich NV/SA, Bornem, Belgium) was pre-
pared at a concentration of 10 mg/ml in methanol, 
fi  lter sterilised and frozen at −20°C until use. Ofl  ox-
acin was obtained from Sigma-Aldrich (St Louis, MO, 
USA), and kanamycin monosulfate from ICN Bio-
medicals Inc. (Aurora, OH, USA). KM was dissolved 
in sterile distilled water, and OFX was dissolved in 
0.1 N NaOH; both drugs were fi  lter sterilised. Stock 
solutions were made at 1 mg/ml and stored at −20°C 
for no more than 6 months. 
Drug susceptibility testing 
DST for RMP was performed in MGIT960 accord-
ing to the manufacturer’s instructions (Becton Dickin-
son Diagnostic Systems, Sparks, MD, USA). The pro-
portion method (PM) was performed on 7H11 agar 
for OFX and KM according to the standard proce-
dure with the following recommended critical con-
centrations: OFX 2 μg/ml, and KM 6 μg/ml (National 
Committee for Clinical and Laboratory Standards).9 
Results were read 21 days after incubation at 37°C in 
5% CO2 atmosphere. 
TLA
A quadrant Petri plate was used and prepared with 
5 ml of 7H11 agar per compartment. One of the 
compartments served as the growth control (GC), an-
other with 1 μg/ml RMP, the third compartment with 
2.0 μg/ml OFX and the last one with 6 μg/ml KM. 
We fi  rst standardised the TLA using different concen-
trations of the inoculum. To avoid false susceptible 
results, we chose a higher concentration of the myco-
bacterial suspension as compared to the standard 
method (dilution 1:100). The inoculum was prepared 
from fresh LJ medium resuspended in sterile distilled 
water, adjusted to a McFarland turbidity No. 1, and 
diluted 1:50. Ten μl of the inoculum was inoculated 
on each compartment. Plates were sealed with para-
fi  lm and incubated at 37°C in a 5% CO2 incubator. 
Plates were read twice weekly for 21 days using a 
conventional microscope (objective 10×). Once the 
GC compartment was positive, resistance was defi  ned 
as any growth appearing in the compartments with 
drugs as compared to the GC compartment. A sus-
ceptible strain was defi  ned as no growth appearing in 
the compartments with drugs compared to the GC. 
Growth detection results in TLA were read blind to 
the results in MGIT960 and the PM.
RESULTS
In a fi  rst step, the TLA method was standardised with 
a panel of eight strains with a known resistance pro-
fi  le. As standardisation of the inoculum is important, 
the actual inoculum size was determined using dif-
ferent concentrations: McFarland 1 diluted in 1/100, 
1/50 and 1/10. Different volumes of the inoculum—
100, 50, 25 and 10 μl—were inoculated in the cen-
tral area of the TLA plate containing the Middle-
brook 7H11 agar and the corresponding drugs. Full 
concordance of results was observed using an inocu-
lum corresponding to a McFarland 1 diluted 1/50 us-
ing 10 μl for inoculation. 
All 147 clinical isolates of M. tuberculosis were 
tested for susceptibility to RMP, OFX and KM. With 
TLA, results were available on an average of 10 days 
of incubation compared to 3 weeks for OFX and KM 
and 8 days for MGIT960. The Table shows the DST 
results obtained by the gold standard method and 
TLA. Among the 147 isolates, 122 were resistant to 
Table  Results of the 147 M. tuberculosis isolates tested by 










  TLA  S 25   0 100 100 100
R  0 122
OFX
  TLA S 95   0 100 100 100
R 0  3 9
KM
  TLA  S 77     0 100     98.7     99.3
R 1  6 7
TLA = thin-layer agar; RMP = rifampicin; OFX = oﬂ  oxacin; KM = kanamy-
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RMP, 39 were resistant to OFX, and 67 were resistant 
to KM. Full agreement was found between the results 
obtained for the detection of RMP and OFX resis-
tance. For KM, one discordant result was classifi  ed as 
false resistant by TLA, giving a sensitivity of 100% 
and a specifi  city of 98.7%. We repeated the test by 
both methods and found the same results. We then 
used the resazurin microtiter assay (REMA) to deter-
mine the minimal inhibitory concentration (MIC) of 
KM for this isolate, according to previously published 
methodology.10 The strain had an MIC of 5 μg/ml, 
which is classifi  ed as resistant to KM. The Figure il-
lustrates a strain susceptible to OFX but resistant to 
RMP and KM.
DISCUSSION
In this study, we have evaluated the TLA on clinical 
isolates of M. tuberculosis for the detection of re-
sistance to RMP, KM and OFX, three key anti-tuber-
culosis drugs in the treatment of TB and MDR-TB. 
The development of new methods for TB diagnosis 
that are able to provide earlier results than the con-
ventional methods is a priority for TB control. With 
the conventional method performed on LJ or 7H11 
medium, results are available only after 1 or 2 months, 
and thus treatment is usually prescribed empirically. 
One disadvantage of the commercially available rapid 
liquid culture techniques, such as the MGIT, is the in-
ability to observe the colony morphology, unlike 
other solid media. Also, for daily routine use, the high 
costs could be an obstacle to its widespread imple-
mentation. Besides standard laboratory equipment, 
TLA requires only a standard microscope. Concerns 
have been voiced about the use of CO2, which favours 
the growth of M. tuberculosis. In a study by Schaberg 
et al., it was found that CO2 incubation allowed M. tu-
berculosis to be detected only 1 day earlier than when 
CO2 was not employed.11 This is an important ques-
tion that needs to be resolved to avoid the need for ex-
pensive CO2 incubators, and further studies are needed 
to confi  rm this observation.
In this study it was important to consider a total 
inhibition of growth for the defi  nition of susceptibil-
ity, to avoid the detection of false-susceptible strains. 
TLA using a quadrant plate format is an alternative 
low-cost method that can reduce the time to detec-
tion of resistance in M. tuberculosis to 10 days com-
pared to several weeks using the conventional pro-
portion method. Microcolonies could be seen under 
the microscope long before they were observed visu-
ally. Although the method is easy to perform, a mini-
mum of training is needed to recognise the growth of 
M. tuberculosis under the microscope and differenti-
ate it from any other bacterial contamination. Charac-
teristic growth cord formation of M. tuberculosis was 
simple to recognise because the study was performed 
on fresh, pure culture. As regards biosafety, a biologi-
cal class II cabinet is recommended, as for any culture 
TB manipulation. TLA can be implemented in an ex-
isting TB culture laboratory, and the need for training, 
evaluation and quality control should be considered. 
The potential risk of aerosols is reduced in TLA com-
pared to the use of other liquid culture media. Using 
TLA directly on sputum samples will avoid the pre-
isolation culture step that requires at least 2 weeks be-
fore performing DST. A recent study evaluated TLA 
directly on sputum samples for the detection of resist-
ance to RMP and INH.12 TLA sensitivity and specifi  -
city for both drugs was 100%, and time to detection 
of resistance was 11 days for smear-positives, show-
ing a performance comparable to conventional DST 
methods. Further operational fi  eld studies are needed, 
especially applying TLA directly on sputum samples, 
to fully validate its usefulness for the rapid detection 
of drug resistance in TB.
Acknowledgements
This study was partially supported by Médecins Sans Frontières, 
Paris, France and by the European Commission under HEALTH-
F3-2007-201690.
References
 1 World Health Organization. Antituberculosis drug resistance 
in the world. Report no. 4. WHO/HTM/TB/2008.394. Geneva, 
Switzerland: WHO, 2008.
  2  World Health Organization. Policy guidance on TB drug suscep-
tibility testing (DST) of second-line drugs (SLD). Geneva, Swit-
zerland: WHO, 2007. http://www.who.int/tb/features_archive/
xdr_mdr_policy_guidance/en Accessed July 2009.
  3 Moore D, Mendoza D, Gilman R H, et al. and the Tubercu-
losis Working Group in Peru. Microscopic observation drug 
Figure  Thin layer agar quadrant plate: A) positive growth con-
trol; B) rifampicin-resistant; C) oﬂ  oxacin-susceptible; D) kana-
mycin-resistant.1304  The   International   Journal   of   Tuberculosis   and   Lung   Disease
susceptibility assay, a rapid, reliable diagnostic test for multidrug-
resistant tuberculosis suitable for use in resource-poor settings. 
J Clin Microbiol 2004; 10: 4432–4437.
 4 Martin A, Panaiotov S, Portaels F, Hoffner S, Palomino J C, 
Angeby K. The nitrate reductase assay for the rapid detection 
of multidrug-resistant M. tuberculosis: a systematic review and 
meta-analysis. J Antimicrob Chemother 2008; 62: 56–65.
  5  Martin A, Portaels F, Palomino J C. Colorimetric redox-indicator 
methods for the rapid detection of multidrug resistance in Myco-
bacterium tuberculosis: a systematic review and meta-analysis. 
J Antimicrob Chemother 2007; 59: 175–183.
  6  Palomino J C. Non-conventional and new methods in the diag-
nosis of tuberculosis: feasibility and applicability in the fi  eld. 
Eur Respir J 2005; 26: 1–12.
  7 Robledo J, Mejia G I, Morcillo N, et al. Evaluation of a rapid 
culture method for tuberculosis diagnosis: a Latin American 
multi-center study. Int J Tuberc Lung Dis 2006; 10: 613–619.
  8 Almeida da Silva P, Wiesel F, Santos Boffo M M, et al. Micro-
colony detection in thin layer agar as an alternative method for 
rapid detection of Mycobacterium tuberculosis in clinical sam-
ples. Brazil J Microbiol 2007; 38: 421–423.
 9 National Committee for Clinical and Laboratory Standards. 
Susceptibility testing of Mycobacteria, Nocardia, and other aero-
bic actinomycetes. Tentative standard, 2nd ed. NCCLS M24-
T20. Wayne, PA, USA: NCCLS, 2000.
  10 Martin A, Camacho M, Portaels F, Palomino J C. Resazurin 
microtiter assay plate testing of Mycobacterium tuberculosis 
susceptibilities to second-line drugs: rapid, simple, and inexpen-
sive method. Antimicrob Agents Chemother 2003; 47: 3616–
3619.
  11 Schaberg T, Reichert B, Schulin T, Lode H, Mauch H. Rapid 
drug susceptibility testing of Mycobacterium tuberculosis us-
ing conventional solid media. Eur Respir J 1995; 8: 1688–
1693. 
  12  Robledo J, Mejia G I, Paniagua L, Martin A, Guzmán A. Rapid 
detection of rifampicin and isoniazid resistance in Mycobacte-
rium tuberculosis by the direct thin-layer agar method. Int J 
Tuberc Lung 2008; 12: 1482–1484.
CONTEXTE :    Dans les pays à faibles revenus, des mé-
thodes économiques de détermination de la sensibilité 
de Mycobacterium tuberculosis aux antibiotiques sont 
nécessaires. 
OBJECTIF :    Evaluer la méthode thin layer agar (culture 
sur agar en couche mince ; TLA) pour la détection ra-
pide de la résistance à la rifampicine (RMP), à l’ofl  oxa-
cine (OFX) et à la kanamycine (KM) dans des isolats cli-
niques de M. tuberculosis et de déterminer, par rapport 
à la méthode de référence, la sensibilité, la spécifi  cité et 
la durée avant positivité de la méthode TLA.
MÉTHODES :  On a étudié 147 isolats cliniques de M. tu-
berculosis. Pour la méthode TLA, on a utilisé une boite 
de Pétri divisée en quatre quartiers préparée avec de l’agar 
7H11 contenant les médicaments correspondants RMP, 
OFX et KM. Les résultats ont été comparés à la méthode 
gold standard MGIT960 pour la RMP et à la méthode 
des proportions sur agar 7H11 pour OFX et KM. 
RÉSULTATS :  La sensibilité et la spécifi  cité pour RMP et 
OFX ont été de 100% et pour KM, la sensibilité a été 
de 100% et la spécifi  cité de 98,7%. L’utilisation de la 
plaque TLA divisée en quatre quartiers permet la détec-
tion rapide de la résistance de M. tuberculosis à l’égard 
des trois médicaments antituberculeux RMP, OFX et 
KM après une durée médiane de 10 jours.
CONCLUSION :  La TLA s’est avéré une méthode précise 
pour la détection de la résistance aux trois médicaments 
étudiés. Cette méthode plus rapide, d’emploi aisé, four-
nit une méthode alternative lorsque des techniques plus 
sophistiquées ne sont pas disponibles dans des contextes 
à faibles revenus. 
MARCO DE REFERENCIA  :    En países de bajos ingresos 
existe una necesidad de métodos económicos de evalu-
ación de la sensibilidad de Mycobacterium tuberculosis 
a los medicamentos. 
OBJETIVO :   Valorar el método de agar en capa delgada 
(TLA) en la detección rápida de la resistencia de M. tu-
berculosis a rifampicina (RMP), ofl  oxacino (OFX) y kana-
micina (KM) a partir de aislados clínicos, y evaluar la 
sen  si  bilidad y la especifi  cidad de esta técnica y el lapso 
ne  cesario hasta obtener un resultado positivo, en com-
paración con el método de referencia. 
MÉTODOS :  Se estudiaron 147 aislados clínicos de M. tu-
berculosis. El TLA se realizó en una caja de Petri divi-
dida en cuadrantes preparada con agar 7H11 que con-
tenía el antibiótico correspondiente : RMP, OFX o KM. 
Los resultados se compararon con el método de referen-
cia, que para la RMP es el sistema MGIT960 y para el 
OFX y la KM es el método proporcional en agar 7H11. 
RESULTADOS :  El método TLA ofreció una sensibilidad 
y una especifi  cidad para la resistencia a RMP y OFX de 
100% y para KM, la sensibilidad fue 100% y la especifi  -
cidad 98,7%. La utilización de una caja de Petri divi-
dida en cuadrantes favoreció la detección rápida de la 
resistencia de M. tuberculosis a los tres medicamentos 
antituberculosos con una mediana de 10 días. 
CONCLUSIÓN :  El TLA fue una técnica precisa en la de-
tección de resistencia a RMP, OFX y KM. Este sistema 
más rápido es de realización sencilla y representa una 
opción cuando no se cuenta con métodos sofi  sticados en 
los entornos con escasos recursos.
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